Table 1

A comparison of CAM therapy users and non user (The sample consists of 908 subjects taking chronic opioids)


CAM user past 12 months
No CAM
Total


n = 404
n = 504
n = 908

Age-Mean
46.6**
50.0**
48.5
Gender, Female
78.6**
61.8**
69.3
Race-White or Caucasian (see footnote 1)
80.9
71.2
75.5
     Black or African American
18.4
26.8
23.1
     Native American
0.5
1.0
0.8
     Hispanic
0.3
1.0
0.7
Education, Mean years (see footnote 2)
13.6**
12.7**
13.1
Education, 12 years or less, %
46.0
62.1
54.9
     >12 and <16 years, %
29.2
23.4
26.0
     16 or more years, %
24.8
14.5
19.1
Employment-Fulltime or part time
49.6*
35.7*
42.0
     Student
1.0
1.0
1.0
     Disability
32.3**
45.6**
39.7
     Unemployed, looking for work
11.9
10.3
11.0
Marital Status-Married
44.2
41.9
42.9
     Widowed
3.5
7.1
5.5
     Separated or Divorced
32.0
31.4
31.6
     Never Married
20.4
19.6
20.0
Opioids Utilization-Daily
86.6
89.3
88.1
     10–29 days per month
13.4
10.7
11.9
     Mean dose of Opioid's per day (footnote 3)
94.1 mg
90.4 mg
92 mg
Opioid addiction (DSM-IV 30 day criteria)
3.6%
3.2%
3.4%
Positive Toxicology test for illicit drugs
21.4%
24.1%
22.1%
Pain severity average daily pain (1–10 scale)
4.83
4.77
4.8
Monthly Employment Income, Mean
$845**
$550**
$681
Total Monthly Income, Mean
$1636**
$1322**
$1461
RAND SF-36 Physical Composite Score
33.5
32.7
33.1
RAND SF-36 Mental Composite Score
46.5*
49.7*
48.3
Primary Pain Site,



     Lower back
34.9*
41.3*
38.4
     Headache
12.9**
7.5**
9.9
     Multiple sites
10.6**
5.9**
8.0
     Knee
5.9
6.9
6.5
     Neck/upper back
9.2**
5.0**
6.8
     Leg
5.0
6.9
6.1
     Foot and ankle
3.5*
7.1*
5.5
     Shoulder
4.7
4.6
4.6
     Hip
4.7
4.4
4.5
     Abdominal
3.5
5.2
4.4

*p < .05, **p < .01

1. Using Chi square analysis Caucasians were more likely to use CAM therapy than African Americans. p < 0.01.

2. Using Chi square analysis subjects who utilized CAM therapy were more likely to have attended college than non CAM users. p < 0.01.

3. Opioids utilized by the chronic pain patients in the sampe (i.e. oxycodone, hydrocodone, methadone, fentanyl, meperidine, codeine) were converted to morphine equivalent doses using standard equivalency tables.

Fleming et al. BMC Complementary and Alternative Medicine 2007 7:15   doi:10.1186/1472-6882-7-15